Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.8M Buy
50,540
+4,468
+10% +$1.59M 0.28% 58
2025
Q4
$15.1M Buy
46,072
+4,331
+10% +$1.37M 0.23% 72
2025
Q3
$11.8M Buy
41,741
+1,301
+3% +$377K 0.19% 106
2025
Q2
$11.2M Buy
40,440
+2,157
+6% +$611K 0.2% 102
2025
Q1
$11.7M Sell
38,283
-11,547
-23% -$3.41M 0.24% 83
2024
Q4
$13M Buy
49,830
+8,393
+20% +$2.49M 0.26% 62
2024
Q3
$11.8M Sell
41,437
-2,022
-5% -$661K 0.3% 64
2024
Q2
$13.6M Buy
43,459
+2,022
+5% +$594K 0.32% 59
2024
Q1
$11.8M Sell
41,437
-274
-0.7% -$80.2K 0.3% 64
2023
Q4
$12M Buy
41,711
+1,703
+4% +$464K 0.36% 48
2023
Q3
$10.8M Buy
40,008
+9,924
+33% +$2.48M 0.38% 38
2023
Q2
$6.68M Sell
30,084
-2,985
-9% -$693K 0.25% 85
2023
Q1
$7.99M Buy
33,069
+9,109
+38% +$2.24M 0.32% 61
2022
Q4
$6.29M Buy
23,960
+2,478
+12% +$664K 0.34% 60
2022
Q3
$4.84M Sell
21,482
-2,934
-12% -$711K 0.33% 68
2022
Q2
$5.94M Sell
24,416
-12,522
-34% -$3.07M 0.41% 41
2022
Q1
$8.93M Buy
36,938
+8,848
+31% +$2.03M 0.62% 19
2021
Q4
$6.32M Buy
28,090
+4,742
+20% +$1M 0.49% 36
2021
Q3
$4.96M Buy
23,348
+3,359
+17% +$773K 0.51% 31
2021
Q2
$4.87M Buy
19,989
+5,761
+40% +$1.42M 0.59% 28
2021
Q1
$3.54M Buy
14,228
+4,524
+47% +$1.08M 0.63% 27
2020
Q4
$2.23M Buy
9,704
+2,395
+33% +$552K 0.59% 27
2020
Q3
$1.86M Buy
7,309
+2,098
+40% +$520K 0.71% 25
2020
Q2
$1.23M Buy
5,211
+669
+15% +$153K 0.7% 33
2020
Q1
$921K Buy
4,542
+431
+10% +$94.1K 0.77% 23
2019
Q4
$991K Buy
+4,111
New +$906K 0.73% 27

Other funds holding AMGN

Ethic Inc's AMGN Position: Q1 2026 in Review

Ethic Inc increased its Amgen (AMGN) stake by 9.7% in Q1 2026, buying an estimated $1.59M and bringing the position to 50,540 shares worth $17.8M. The position accounts for 0.28% of the portfolio, ranked #58.

Ethic Inc first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ethic Inc held 50,540 shares of Amgen worth $17.8M as of Q1 2026.
  • Ethic Inc bought 4,468 Amgen shares in Q1 2026, an estimated $1.59M.
  • Amgen made up 0.28% of Ethic Inc's portfolio in Q1 2026, its #58 holding.
  • Ethic Inc first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.